Best Buy (BBY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Shareholders are invited to vote at the annual meeting scheduled for June 12, 2026, with virtual participation available.
Voting covers director elections, auditor ratification, executive compensation, and two shareholder proposals.
Voting matters and shareholder proposals
Election of 13 directors is proposed, with board recommending a vote for all nominees.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending January 30, 2027 is recommended.
Advisory vote on executive compensation is recommended for approval.
Board recommends voting against shareholder proposals on non-fiduciary executive compensation metrics and a sustainability ROI report.
Board of directors and corporate governance
Nominees for director include Corie S. Barry, Lisa M. Caputo, Meghan C. Frank, and others, totaling 13 candidates.
Latest events from Best Buy
- Board recommends director slate, auditor, and pay; opposes new ESG/compensation reports.BBY
Proxy filing1 May 2026 - AI-driven innovation, Marketplace growth, and resilient supply chain strategies fuel future success.BBY
UBS Global Consumer and Retail Conference12 Mar 2026 - Q4 profit rose on stable sales; FY27 outlook sees margin gains and strong capital returns.BBY
Q4 20263 Mar 2026 - Omnichannel strategy, innovation, and AI are driving growth amid evolving consumer trends.BBY
Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference1 Feb 2026 - EPS up, margins improved, and FY25 guidance raised despite 3.1% revenue decline.BBY
Q2 202523 Jan 2026 - Q3 sales declined but gross margin and capital returns improved amid cautious FY25 guidance.BBY
Q3 202512 Jan 2026 - Q4 beat expectations; FY26 outlook steady, with tariffs and shareholder returns in focus.BBY
Q4 20257 Jan 2026 - Shareholders approved all board recommendations, with key topics including compensation, buybacks, and risk.BBY
AGM 20256 Jan 2026 - Adjusted EPS up 11% to $1.40, but GAAP EPS fell on health impairments and restructuring.BBY
Q3 20265 Dec 2025